Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 1, 2011, Pages 45-53

  Lin, Wei Chieh ^a   Lin, Chiou Feng ^a   Chen, Chia Ling ^a   Chen, Chang Wen ^b   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CERAMIDE; CHLORPROMAZINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; SPHINGOLACTONE 24; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE INHIBITOR II; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASE REPORT; CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRONCHOSCOPY; CASPASES; CERAMIDES; FIBER OPTIC TECHNOLOGY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C3H; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 80053147547     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.181560     Document Type: Article

References (41)

1. Abraham E, Carmody A, Shenkar R, and Arcaroli J (2000) Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 279:L1137-L1145. (Pubitemid 32009500)
2. Aggarwal A, Baker CS, Evans TW, and Haslam PL (2000) G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15:895-901. (Pubitemid 30321847)
3. Alvarado-Kristensson M, Porn-Ares MI, Grethe S, Smith D, Zheng L, and Andersson T (2002) p38 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J 16:129-131.
4. Arcaroli J, Yum HK, Kupfner J, Park JS, Yang KY, and Abraham E (2001) Role of p38 MAP kinase in the development of acute lung injury. Clin Immunol 101:211-219.
5. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, and Lin YS (2008) Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin- interacting protein-mediated pathway. Blood 111:4365-4374.
6. Chihab R, Pörn-Ares MI, Alvarado-Kristensson M, and Andersson T (2003) Sphingosine 1-phosphate antagonizes human neutrophil apoptosis via p38 mitogenactivated protein kinase. Cell Mol Life Sci 60:776-785. (Pubitemid 36570768)
7. Cogolludo A, Moreno L, Frazziano G, Moral-Sanz J, Menendez C, Castaňeda J, González C, Villamor E, and Perez-Vizcaino F (2009) Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res 82:296-302.
8. Delgado A, Casas J, Llebaria A, Abad JL, and Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 1758:1957-1977. (Pubitemid 44879369)
9. Diab KJ, Adamowicz JJ, Kamocki K, Rush NI, Garrison J, Gu Y, Schweitzer KS, Skobeleva A, Rajashekhar G, Hubbard WC, et al. (2010) Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. Am J Respir Crit Care Med 181:344-352.
10. Folkesson HG, Matthay MA, Hébert CA, and Broaddus VC (1995) Acid aspirationinduced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96:107-116.
11. Fotouhi-Ardakani N, Kebir DE, Pierre-Charles N, Wang L, Ahern SP, Filep JG, and Milot E (2010) Role for myeloid nuclear differentiation antigen in the regulation of neutrophil apoptosis during sepsis. Am J Respir Crit Care Med 182:341-350.
12. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, and Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969. (Pubitemid 37187498)
13. Gilroy DW, Lawrence T, Perretti M, and Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3:401-416. (Pubitemid 38618123)
14. Göggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schütze S, et al. (2004) PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10:155-160. (Pubitemid 38524885)
15. Goldkorn T and Filosto S (2010) Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 43:259-268.
16. Hannun YA and Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150. (Pubitemid 351158911)
17. Jung ID, Lee JS, Kim YJ, Jeong YI, Lee CM, Lee MG, Ahn SC, and Park YM (2007) Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology 121:533-544.
18. Keel M, Ungethüm U, Steckholzer U, Niederer E, Hartung T, Trentz O, and Ertel W (1997) Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90:3356-3363. (Pubitemid 27473403)
19. Lee C, Xu DZ, Feketeova E, Kannan KB, Yun JK, Deitch EA, Fekete Z, Livingston DH, and Hauser CJ (2004) Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. J Trauma 57:955-960. (Pubitemid 39579278)
20. Lesur O, Kokis A, Hermans C, Fülöp T, Bernard A, and Lane D (2000) Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med 28:3814-3822. (Pubitemid 32044477)
21. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256. (Pubitemid 36444440)
22. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH Jr, et al. (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280:37118-37129. (Pubitemid 41587796)
23. Mathias S, Peña LA, and Kolesnick RN (1998) Signal transduction of stress via ceramide. Biochem J 335:465-480. (Pubitemid 28515396)
24. Matute-Bello G, Liles WC, Radella F, 2nd, Steinberg KP, Ruzinski JT, Hudson LD, and Martin TR (2000) Modulation of neutrophil apoptosis by granulocyte colonystimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 28:1-7. (Pubitemid 30091021)
25. McVerry BJ and Garcia JG (2005) In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal 17:131-139. (Pubitemid 39371042)
26. Nick JA, Young SK, Arndt PG, Lieber JG, Suratt BT, Poch KR, Avdi NJ, Malcolm KC, Taube C, Henson PM, et al. (2002) Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen- activated protein kinase. J Immunol 169:5260-5269. (Pubitemid 35217198)
27. Nishiuma T, Nishimura Y, Okada T, Kuramoto E, Kotani Y, Jahangeer S, and Nakamura S (2008) Inhalation of sphingosine kinase inhibitor attenuates airwayinflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol 294:L1085-L1093.
28. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, and Garcia JG (2004) Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169: 1245-1251. (Pubitemid 38680403)
29. Ren S, Xin C, Pfeilschifter J, and Huwiler A (2010) A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p- chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation. Cell Physiol Biochem 26:97-104.
30. Sensken SC, Bode C, and Gräler MH (2009) Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J Pharmacol Exp Ther 328: 963-969.
31. Spiegel S and Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407. (Pubitemid 36565571)
32. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671-1684.
33. Strub GM, Maceyka M, Hait NC, Milstien S, and Spiegel S (2010) Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol 688:141-155.
34. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, and Marshall JC (2004) Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med 32:1460-1469. (Pubitemid 38925173)
35. Uhlig S and Gulbins E (2008) Sphingolipids in the lungs. Am J Respir Crit Care Med 178:1100-1114.
36. Verdurmen WP, Thanos M, Ruttekolk IR, Gulbins E, and Brock R (2010) Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake. J Control Release 147:171-179.
37. Von Bismarck P, Wistädt CF, Klemm K, Winoto-Morbach S, Uhlig U, Schütze S, Adam D, Lachmann B, Uhlig S, and Krause MF (2008) Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. Am J Respir Crit Care Med 177:1233-1241. (Pubitemid 351860932)
38. Wheeler AP and Bernard GR (2007) Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369:1553-1564. (Pubitemid 46670280)
39. Yang DI, Yeh CH, Chen S, Xu J, and Hsu CY (2004) Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide. Neurobiol Dis 17:99-107. (Pubitemid 39209317)
40. Zambon M and Vincent JL (2008) Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 133:1120-1127. (Pubitemid 351685515)
41. Zemans RL, Colgan SP, and Downey GP (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40:519-535.